Improving outcomes with anti-BCMA bispecific antibodies with attention to infection - Poll - MDSpire

Improving outcomes with anti-BCMA bispecific antibodies with attention to infection

  • By

  • Andrew J. Yee

  • July 8, 2024

  • 0 min

Share

Original Source(s)

Improving outcomes with anti-BCMA bispecific antibodies with attention to infection

  • by Andrew J. Yee

  • July 8, 2024

Related Content

Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review

Advancing CAR-T therapy in multiple myeloma: a critical appraisal of CARTITUDE-4 and the path toward earlier lines

Infection risk associated with teclistamab in relapsed/refractory multiple myeloma: a systematic review and meta-analysis of clinical trial and real-world evidence